- Type / Class
- Equity / Common Stock
- Shares outstanding
- 46,821,220
- Total 13F shares
- 5,644,984
- Share change
- +174
- Total reported value
- $106,633,384
- Price per share
- $18.89
- Number of holders
- 11
- Value change
- +$3,288
- Number of buys
- 1
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 63009J107?
CUSIP 63009J107 identifies NBTX - Nanobiotix S.A. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 63009J107:
Top shareholders of NBTX - Nanobiotix S.A. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON |
13F
|
Company |
12%
|
5,623,816
|
$25,454,516 | — | 30 Jun 2025 | |
| Invus Global Management, LLC |
13D/G
|
Invus Public Equities, L.P. |
8.9%
|
4,232,829
|
$13,545,053 | $0 | 31 Dec 2023 | |
| BAILLIE GIFFORD & CO |
13D/G
|
— |
4.1%
|
1,919,670
|
$6,142,944 | $0 | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
10,184
|
$48,170 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
5,300
|
$25,069 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,418
|
$20,897 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
761
|
$3,600 | — | 30 Jun 2025 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
517
|
$2,445 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
125
|
$1,000 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
33
|
$156 | — | 30 Jun 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
13
|
$61 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
4
|
$19 | — | 30 Jun 2025 |
Institutional Holders of Nanobiotix S.A. - Common Stock (NBTX) as of Q3 2025
As of 30 Sep 2025,
Nanobiotix S.A. - Common Stock (NBTX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,644,984 shares.
The largest 10 holders included
JOHNSON & JOHNSON, GEODE CAPITAL MANAGEMENT, LLC, Optiver Holding B.V., MORGAN STANLEY, UBS Group AG, EverSource Wealth Advisors, LLC, BNP PARIBAS FINANCIAL MARKETS, ROYAL BANK OF CANADA, RHUMBLINE ADVISERS, and NATIONAL BANK OF CANADA /FI/.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
8
Q3 2025 holders
11
Holder diff
3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.